Structures by: Arhangelskis M.
Total: 72
Nicotineamide adipic
C6H10O4,C6H6N2O
Chemical Science (2020)
a=4.9815(2)Å b=30.3259(19)Å c=8.9413(4)Å
α=90° β=93.776(4)° γ=90°
Work
C14H14AgN4,CF3O3S
CrystEngComm (2020)
a=13.335(4)Å b=16.400(5)Å c=8.497(3)Å
α=90.00° β=93.567(5)° γ=90.00°
Work
C15H16N4,2(H2O)
CrystEngComm (2020)
a=17.2606(4)Å b=10.9538(3)Å c=8.1564(2)Å
α=90.00° β=101.4550(10)° γ=90.00°
Work
C14H14N4,2(H2O)
CrystEngComm (2020)
a=16.748(7)Å b=9.455(4)Å c=4.562(2)Å
α=90.00° β=100.666(8)° γ=90.00°
Work
C16H16AgF3N4O3S
CrystEngComm (2020)
a=13.3761(7)Å b=16.6393(10)Å c=8.5931(5)Å
α=90.00° β=93.452(3)° γ=90.00°
Catena-(ammonium bis(m2-oxalato)-scandium dihydrate)
C4O8Sc,2(O),(N)
Green Chemistry (2020) 22, 13 4364-4375
a=9.0093(2)Å b=9.0093(2)Å c=11.2503(4)Å
α=90° β=90° γ=120°
Sodium scandium oxalate hexahydrate
C6H10Na3O18Sc
Green Chemistry (2020) 22, 13 4364-4375
a=17.851(2)Å b=11.0413(7)Å c=18.2806(13)Å
α=90° β=104.189(2)° γ=90°
C7H12K3.5O20Sc
C7H12K3.5O20Sc
Green Chemistry (2020) 22, 13 4364-4375
a=15.8839(14)Å b=11.4558(10)Å c=22.7314(19)Å
α=90° β=92.190(4)° γ=90°
Catena-(ammonium bis(m2-oxalato)-ytterbium hydrate)
C4O9Yb,N
Green Chemistry (2020) 22, 13 4364-4375
a=9.0427(2)Å b=6.09117(12)Å c=7.8999(2)Å
α=90° β=90.182(3)° γ=90°
Catena-(potassium bis(m2-oxalato)-europium hydrate)
C6EuO13,2(O),3(K)
Green Chemistry (2020) 22, 13 4364-4375
a=8.4883(2)Å b=9.3894(3)Å c=9.7552(2)Å
α=98.255(2)° β=91.154(2)° γ=96.544(3)°
Tripotassium gadolinium oxalate trihydrate
C6H6GdK3O15
Green Chemistry (2020) 22, 13 4364-4375
a=8.4795(8)Å b=9.3708(9)Å c=9.7323(9)Å
α=98.377(4)° β=91.097(4)° γ=96.629(4)°
Potassium scandium oxalate
3K,[ScC6O12]3,2[H2O]
Green Chemistry (2020) 22, 13 4364-4375
a=11.4151(8)Å b=12.6781(9)Å c=11.4093(8)Å
α=90° β=111.900(2)° γ=90°
2(C6F4I2),C6H12N2
2(C6F4I2),C6H12N2
Chemical communications (Cambridge, England) (2020) 56, 59 8293-8296
a=7.5107(5)Å b=12.8506(8)Å c=13.4853(9)Å
α=94.235(2)° β=102.514(2)° γ=102.883(2)°
C6H12N2,C6F4I2
C6H12N2,C6F4I2
Chemical communications (Cambridge, England) (2020) 56, 59 8293-8296
a=8.4114(6)Å b=11.1190(8)Å c=17.6646(11)Å
α=90° β=103.661(3)° γ=90°
C6F4I2,2(C6H12N2)
C6F4I2,2(C6H12N2)
Chemical communications (Cambridge, England) (2020) 56, 59 8293-8296
a=6.5273(5)Å b=17.4784(13)Å c=19.2084(14)Å
α=90° β=90° γ=90°
C6H12N2,C6F4I2
C6H12N2,C6F4I2
Chemical communications (Cambridge, England) (2020) 56, 59 8293-8296
a=6.7231(5)Å b=14.0970(10)Å c=17.5147(13)Å
α=76.882(3)° β=80.884(3)° γ=78.615(2)°
2(C13H13OP),C6F4I2
2(C13H13OP),C6F4I2
Chemical Communications (2019)
a=6.04730(10)Å b=12.0007(2)Å c=12.56410(10)Å
α=116.0359(6)° β=100.5276(7)° γ=94.7799(7)°
2(C13H13OP),C6F4I2
2(C13H13OP),C6F4I2
Chemical Communications (2019)
a=11.5273(4)Å b=5.88431(18)Å c=23.5890(7)Å
α=90° β=90.628(3)° γ=90°
2(C13H13OP),C6F4I2
2(C13H13OP),C6F4I2
Chemical Communications (2019)
a=5.72260(10)Å b=16.3731(3)Å c=32.1528(7)Å
α=90° β=90° γ=90°
2(C13H13OP),C6F4I2
2(C13H13OP),C6F4I2
Chemical Communications (2019)
a=6.0447(4)Å b=11.5656(6)Å c=12.5757(7)Å
α=113.430(5)° β=100.733(5)° γ=97.582(5)°
C13H13OP
C13H13OP
Chemical Communications (2019)
a=8.6356(4)Å b=24.2366(12)Å c=16.6059(9)Å
α=90° β=101.535(5)° γ=90°
2(C7H8N4O2),3(C4H7NO)
2(C7H8N4O2),3(C4H7NO)
CrystEngComm (2019) 21, 13 2097
a=7.5056(3)Å b=25.0862(9)Å c=15.2376(6)Å
α=90° β=93.195(2)° γ=90°
C7H8N4O2,C4H7NO
C7H8N4O2,C4H7NO
CrystEngComm (2019) 21, 13 2097
a=6.6482(3)Å b=8.7311(4)Å c=10.9852(5)Å
α=82.631(2)° β=84.273(2)° γ=83.701(3)°
Fumaric acid:Pyrazine cocrystal
C4H4O4,C4H4N2
CrystEngComm (2012) 14, 16 5203
a=5.1006(7)Å b=6.1168(8)Å c=6.9894(10)Å
α=85.396(11)° β=82.199(12)° γ=85.176(11)°
Pyrazine:phtalic acid cocrystal
C8H6O4,C4H4N2
CrystEngComm (2012) 14, 16 5203
a=6.93440(24)Å b=13.59704(73)Å c=14.51054(72)Å
α=90° β=122.2085(29)° γ=90°
C4H6O4,C4H4N2
C4H6O4,C4H4N2
CrystEngComm (2012) 14, 16 5203
a=8.5311(4)Å b=5.1286(2)Å c=10.2947(5)Å
α=90.00° β=103.012(5)° γ=90.00°
Pyrazine:terephthalic acid cocrystal
C8H6O4,C4H4N2
CrystEngComm (2012) 14, 16 5203
a=3.81056(10)Å b=7.07204(32)Å c=11.50344(44)Å
α=94.9505(15)° β=93.5324(20)° γ=115.2753(18)°
Catena-(tetra-aqua-tris(m2-oxalato-O,O',O'',O''')-di-lutecium(iii)) dihydrate
C3LuO8,O
Green Chemistry (2020) 22, 13 4364-4375
a=9.5867(2)Å b=6.64358(16)Å c=6.25859(16)Å
α=98.1966(17)° β=99.4509(19)° γ=75.113(2)°
Ethenzamide-24Dihydroxybenzoic acid
C7H5O4,C9H11NO2
CrystEngComm (2017) 19, 5 826
a=9.6638(17)Å b=6.6901(11)Å c=24.670(4)Å
α=90° β=99.732(8)° γ=90°
Ethenzamide-35Dihydroxybenzoicacid dihydrate
C9H11NO2,3(C7H6O4),2(H2O)
CrystEngComm (2017) 19, 5 826
a=11.1756(12)Å b=11.7633(14)Å c=12.2009(14)Å
α=95.319(8)° β=102.434(7)° γ=100.852(7)°
Ethenzamide Ferulic acid
C10H10O4,C9H11NO2
CrystEngComm (2017) 19, 5 826
a=15.539(2)Å b=7.4265(10)Å c=31.796(4)Å
α=90° β=90° γ=90°
C13H9BrN1,Br1,H2O
C13H9BrN1,Br1,H2O
CrystEngComm (2014) 16, 47 10830
a=7.3152(6)Å b=9.7141(9)Å c=10.352(2)Å
α=68.687(3)° β=86.209(3)° γ=68.298(4)°
C13H9IN1,I31
C13H9IN1,I31
CrystEngComm (2014) 16, 47 10830
a=7.5081(3)Å b=10.4940(5)Å c=11.7322(6)Å
α=105.219(2)° β=105.581(2)° γ=101.791(2)°
C14H12N1,Br1,H2O
C14H12N1,Br1,H2O
CrystEngComm (2014) 16, 47 10830
a=7.7990(10)Å b=9.585(2)Å c=9.664(2)Å
α=68.967(7)° β=70.925(6)° γ=83.339(6)°
C34H36N22,2(Br1),H2O
C34H36N22,2(Br1),H2O
CrystEngComm (2014) 16, 47 10830
a=7.7034(7)Å b=9.1410(10)Å c=12.257(2)Å
α=88.730(6)° β=78.321(6)° γ=71.486(4)°
C13H9IN1,Br1,H2O
C13H9IN1,Br1,H2O
CrystEngComm (2014) 16, 47 10830
a=7.5841(6)Å b=19.2894(16)Å c=9.3211(9)Å
α=90° β=105.886(4)° γ=90°
Fluorescein:phenantridine cocrystal
(C20H12O5),(C13H9N1)2
CrystEngComm (2013) 15, 32 6289
a=27.7697(34)Å b=15.4238(20)Å c=7.98164(85)Å
α=90° β=90° γ=90°
Fluorescein:acridine cocrystal
(C20H12O5),(C13H9N1)2
CrystEngComm (2013) 15, 32 6289
a=25.2998(38)Å b=16.8440(27)Å c=7.88987(81)Å
α=90° β=90° γ=90°
Fluorescein:pyrazine cocrystal
(C20H12O5),(C4H4N2)
CrystEngComm (2013) 15, 32 6289
a=7.81238(87)Å b=19.0241(17)Å c=12.7880(14)Å
α=90° β=91.1378(67)° γ=90°
C20H12O5,2(C13H9N)
C20H12O5,2(C13H9N)
CrystEngComm (2013) 15, 32 6289
a=27.6912(12)Å b=15.3574(9)Å c=7.8814(4)Å
α=90° β=90° γ=90°
C20H12O5,2(C13H9N)
C20H12O5,2(C13H9N)
CrystEngComm (2013) 15, 32 6289
a=8.6428(3)Å b=19.6270(7)Å c=20.9268(9)Å
α=90° β=98.748(4)° γ=90°
C40H24O10,C4H4N2,2(CH4O)
C40H24O10,C4H4N2,2(CH4O)
CrystEngComm (2013) 15, 32 6289
a=7.6060(4)Å b=11.1161(9)Å c=12.0927(8)Å
α=115.965(7)° β=93.139(5)° γ=92.811(6)°
C13H9FN1,Br1,H2O
C13H9FN1,Br1,H2O
CrystEngComm (2014) 16, 47 10830
a=10.4896(4)Å b=12.9381(5)Å c=9.9423(3)Å
α=90° β=117.876(3)° γ=90°
C13H9ClN1,Br1,0.75(H2O)
C13H9ClN1,Br1,0.75(H2O)
CrystEngComm (2014) 16, 47 10830
a=9.5818(3)Å b=11.4519(3)Å c=12.5667(4)Å
α=109.027(2)° β=94.230(2)° γ=105.253(2)°
Caffeine:anthranilic acid co-crystal
C8H10N4O2,C7H7NO2
Acta Crystallographica Section B (2014) 70, 1 72-80
a=14.53798(14)Å b=11.07930(8)Å c=10.02456(7)Å
α=90° β=90° γ=90°
Caffeine:anthranilic acid co-crystal
C8H10N4O2,C7H7NO2
Acta Crystallographica Section B (2014) 70, 1 72-80
a=8.4853(2)Å b=13.4240(3)Å c=14.8856(4)Å
α=111.7249(16)° β=92.8464(15)° γ=93.5278(9)°
Caffeine:anthranilic acid hemichlorobenzene
2(C8H10N4O2),2(C7H7NO2),C6H5Cl
Acta Crystallographica Section B (2014) 70, 1 72-80
a=12.4390(2)Å b=13.1409(2)Å c=13.2251(3)Å
α=69.439(1)° β=80.418(1)° γ=63.557(1)°
Caffeine:anthranilic acid hemitoluene
2(C8H10N4O2),2(C7H7NO2),C7H8
Acta Crystallographica Section B (2014) 70, 1 72-80
a=12.475(9)Å b=13.488(9)Å c=13.316(9)Å
α=68.318(11)° β=79.948(16)° γ=64.124(11)°
Caffeine:anthranilic acid hemibromobenzene
2(C8H10N4O2),2(C7H7NO2),C6H5Br
Acta Crystallographica Section B (2014) 70, 1 72-80
a=12.569(3)Å b=13.409(3)Å c=13.269(3)Å
α=68.991(4)° β=80.215(5)° γ=64.007(4)°
Caffeine:anthranilic acid mono o-xylene
C8H10N4O2,C7H7NO2,C8H10
Acta Crystallographica Section B (2014) 70, 1 72-80
a=13.8492(3)Å b=6.7890(2)Å c=23.3960(7)Å
α=90.00° β=92.260(1)° γ=90.00°
Caffeine:anthranilic acid mono toluene
C8H10N4O2,C7H7NO2,C7H8
Acta Crystallographica Section B (2014) 70, 1 72-80
a=6.7113(3)Å b=13.5803(6)Å c=23.579(2)Å
α=87.100(2)° β=88.572(2)° γ=86.065(2)°
Theobromine:anthranilic acid co-crystal
C7H8N4O2,C7H7NO2
Acta Crystallographica Section B (2014) 70, 1 72-80
a=6.5769(10)Å b=21.905(3)Å c=11.0496(16)Å
α=90° β=112.912(6)° γ=90°
Caffeine:anthranilic acid sesqui p-xylene
C8H10N4O2,C7H7NO2,1.5(C8H10)
Acta Crystallographica Section B (2014) 70, 1 72-80
a=6.8474(8)Å b=13.431(2)Å c=14.440(3)Å
α=77.009(3)° β=86.596(4)° γ=88.687(8)°
Caffeine:anthranilic acid monohydrate
C8H10N4O2,C7H7NO2,H2O
Acta Crystallographica Section B (2014) 70, 1 72-80
a=10.2641(2)Å b=26.9469(7)Å c=11.9845(3)Å
α=90.00° β=103.547(2)° γ=90.00°
Catena-(bis(m2-1,2,4-triazolato)-zinc)
C4H4N6Zn
Chemistry of Materials (2020)
a=9.9588(3)Å b=9.7770(3)Å c=14.1456(4)Å
α=90° β=90° γ=90°
Catena-(tetrakis(m2-2-Butylimidazolato)-di-zinc)
C14H22N4Zn
Chemistry of Materials (2019) 31, 13 4882
a=26.7649(18)Å b=26.7649(18)Å c=26.7649(18)Å
α=90° β=90° γ=90°
Catena-(tetrakis(m2-2-trifluoromethylimidazolato)-di-zinc)
C8H4F6N4Zn
Chemistry of Materials (2019) 31, 10 3777
a=8.8027(4)Å b=8.8027(4)Å c=12.7893(6)Å
α=90° β=90° γ=120°
Catena-(tetrakis(m2-2-trifluoromethylimidazolato)-di-zinc)
C8H4F6N4Zn
Chemistry of Materials (2019) 31, 10 3777
a=17.5317(8)Å b=17.5317(8)Å c=17.5317(8)Å
α=90° β=90° γ=90°
C4H3F3N2
C4H3F3N2
Chemistry of Materials (2019) 31, 10 3777
a=7.5862(16)Å b=9.8792(18)Å c=7.6926(18)Å
α=90° β=108.970(18)° γ=90°
1:1 theophylline benzamide cocrystal Form I
C7H8N4O2,C7H7NO
Crystal Growth & Design (2015)
a=7.5275(2)Å b=13.3891(4)Å c=13.8564(4)Å
α=90.00° β=91.486(2)° γ=90.00°
1:1 theophylline acetamide cocrystal
C7H8N4O2,C2H5NO
Crystal Growth & Design (2015)
a=7.6545(13)Å b=8.3489(14)Å c=8.9540(16)Å
α=90.552(8)° β=91.339(11)° γ=110.177(12)°
1:1 theophylline N,N-dimethylformamide cocrystal
C7H8N4O2,C3H7NO
Crystal Growth & Design (2015)
a=4.4183(1)Å b=14.3872(6)Å c=19.3622(9)Å
α=90.00° β=93.41(3)° γ=90.00°
1:1 theophylline formamide cocrystal Form I
C7H8N4O2,CH3NO
Crystal Growth & Design (2015)
a=8.7314(3)Å b=6.6582(3)Å c=8.8996(4)Å
α=90.00° β=98.546(2)° γ=90.00°
1:1 theophylline formamide cocrystal Form II
C7H8N4O2,CH3NO
Crystal Growth & Design (2015)
a=6.6058(13)Å b=8.7163(17)Å c=8.8843(18)Å
α=81.34(3)° β=87.63(3)° γ=87.47(3)°
1:1 theophylline N-methylformamide cocrystal
C7H8N4O2,C2H5NO
Crystal Growth & Design (2015)
a=6.6316(3)Å b=8.7905(4)Å c=9.5955(4)Å
α=92.441(2)° β=92.929(2)° γ=90.609(2)°
1:1 theophylline pyrazinamide cocrystal Form II
C7H8N4O2,C5H5N3O
Crystal Growth & Design (2015)
a=7.4800(2)Å b=7.6959(2)Å c=12.7028(4)Å
α=86.113(2)° β=75.930(2)° γ=68.995(2)°
1:1 theophylline pyrazinamide cocrystal Form I
(C7H8N4O2),(C5H5N3O1)
Crystal Growth & Design (2015)
a=13.4545(15)Å b=13.2880(19)Å c=7.62149(40)Å
α=90° β=90° γ=90°
Ethenzamide-35Dihydroxybenzoic acid
C9H11NO2,C7H6O4
CrystEngComm (2017) 19, 5 826
a=14.9229(8)Å b=18.9781(13)Å c=21.8605(14)Å
α=90° β=90° γ=90°
9-tert-butylacridizinium bromide monohydrate
(C17H18N11)(Br1)(H2O)
CrystEngComm (2014) 16, 47 10830
a=18.08801(59)Å b=12.04679(49)Å c=7.22980(19)Å
α=90° β=90° γ=90°
Vinpocetine oxalate
C2HO4,C22H27N2O2
Chemical Science (2021)
a=18.5604(11)Å b=7.5949(4)Å c=8.0212(5)Å
α=90° β=96.383(5)° γ=90°
C22H27N2O2,C2HO4
C22H27N2O2,C2HO4
Chemical Science (2021)
a=17.9007(2)Å b=6.30220(10)Å c=20.9554(2)Å
α=90° β=105.3560(10)° γ=90°
C22H27N2O2,C2HO4,0.158(C4H8O2)
C22H27N2O2,C2HO4,0.158(C4H8O2)
Chemical Science (2021)
a=17.8855(2)Å b=6.32180(10)Å c=21.0313(3)Å
α=90° β=105.3460(10)° γ=90°